SEL24-B489

CAS No. 1616359-00-2

SEL24-B489( SEL24 )

Catalog No. M12358 CAS No. 1616359-00-2

SEL24-B489 (SEL24) is a potent, dual PIM and FLT3-ITD inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 148 In Stock
10MG 236 In Stock
25MG 377 In Stock
50MG 529 In Stock
100MG 731 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    SEL24-B489
  • Note
    Research use only, not for human use.
  • Brief Description
    SEL24-B489 (SEL24) is a potent, dual PIM and FLT3-ITD inhibitor.
  • Description
    SEL24-B489 (SEL24) is a potent, dual PIM and FLT3-ITD inhibitor with Kd of 2/2/3 nM for PIM1/2/3, Kd of 160/16 nM for FLT3-WT/FLT3-ITD, respectively; exhibits significantly broader on-target activity in AML cell lines (MV-4-11 GI50=20 nM) and primary AML blasts than selective FLT3-ITD or PIM inhibitors, decreases viability of AML cells with FLT3-TKD mutations associated with resistance to selective FLT3-ITD inhibitors; inhibits the growth of a broad panel of AML cell lines in xenograft models.Blood Cancer Phase 2 Clinical
  • In Vitro
    In MOLM-13 and to a lesser extent in MV4-11 cells, a dose-dependent disruption of cell cycle with especially pronounced depletion of the S phase after treatment with SEL24-B489, accompanied by PARP cleavage and apoptosis was observed.SEL24-B489 causes a profound inhibition of S6 (S235/236), but has little effect on PI3K/mTOR signaling.SEL24-B489 inhibits STAT5 (Ser726) and reduced expression of MCL1, whereas none of the selective inhibitors altered c-MYC abundance or induced PARP cleavage. Cell Viability AssayCell Line:AZD1208, AC220 and AraC in AML cell lines.Concentration:0-10 μM.Incubation Time:72 h. Result:Decreased viability.
  • In Vivo
    SEL24-B489 (25-100 mg/kg, orally) exhibited activity in AML in vivo models.SEL24-B489 induces apoptosis of DLBCL cell lines in low/sub-micromolar concentrations and exhibits activity in a xenograft model. Animal Model:SCID/beige mice bearing MV-4-11 tumors (FLT3-ITD+).Dosage:50, 75 and 100 mg/kg.Administration:Orally, twice daily.Result:Marked dose – dependent tumor reduction (67%, 74% and 82% tumor growth inhibition (TGI) for 50, 75 and 100 mg/kg daily doses, respectively).
  • Synonyms
    SEL24
  • Pathway
    JAK/STAT Signaling
  • Target
    Pim
  • Recptor
    Pim
  • Research Area
    Cancer
  • Indication
    Blood cancer

Chemical Information

  • CAS Number
    1616359-00-2
  • Formula Weight
    446.143
  • Molecular Formula
    C15H18Br2N4O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 25 mg/mL (56.04 mM)
  • SMILES
    CC(N1C(C2CCNCC2)=NC3=C([N+]([O-])=O)C(Br)=C(Br)C=C31)C.[H]Cl
  • Chemical Name
    5,6-dibromo-4-nitro-2-(piperidin-4-yl)-1-(propan-2-yl)-1H-1,3-benzodiazole

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Czardybon W, et al. Oncotarget. 2018 Mar 30;9(24):16917-16931. 2. Bia?opiotrowicz E, et al. J Cell Mol Med. 2018 Apr 17. doi: 10.1111/jcmm.13632. 3. Szyd?owski M, et al. Blood. 2017 Sep 21;130(12):1418-1429.
molnova catalog
related products
  • Tenacigenin B, 3-O-β...

    3-O-beta-Allopyranosyl-(1->4)-beta-oleandropyranosyl-11-O-isobutyryl-12-O-acetyltenacigenin B is a chemical constituent of the plant Poria cocos .

  • K00135

    K00135 is a selective inhibitor of Pim kinases and can be used in studies about gastric cancer and antileukemic therapeutics.

  • Taprenepag

    Taprenepag (CP-544326) is a potent and selective prostaglandin E2 receptor agonist (EC50 = 2.8 nM).